Epstein-Barr virus
Clinical trials for Epstein-Barr virus explained in plain language.
Never miss a new study
Get alerted when new Epstein-Barr virus trials appear
Sign up with your email to follow new studies for Epstein-Barr virus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA vaccine targets Epstein-Barr virus in early trial
Vaccine Recruiting nowThis early-stage trial is testing an mRNA vaccine called mRNA-1189 to see if it is safe and triggers an immune response against Epstein-Barr virus (EBV). EBV is a common virus that can cause mononucleosis and is linked to certain cancers. The study involves 120 healthy adults age…
Matched conditions: EPSTEIN-BARR VIRUS
Phase 1 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:00 UTC
-
Can specially grown immune cells from donors beat viruses that won't go away?
Disease control Recruiting nowThis early-phase trial is testing whether immune cells called R-MVST cells, grown quickly from a healthy donor, can safely fight off stubborn viral infections (EBV, CMV, adenovirus, or BK virus) in children and young adults with weakened immune systems. Participants have not resp…
Matched conditions: EPSTEIN-BARR VIRUS
Phase 1 • Sponsor: Monica Bhatia • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
10,000 people tested: Cambodia's massive disease hunt begins
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for 57 different infectious diseases, including dengue, flu, and malaria. Researchers want to understand how these diseases spread and who is at risk. The goal is to give local health authorities the information they need to create b…
Matched conditions: EPSTEIN-BARR VIRUS
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC